Suviray® 70 mg/ml
Brand Name: Suviray® 70 mg/mL
Composition:Erenumab solution for injection (70 mg/mL).
Manufacturer: Novartis India Ltd.
Product Description
Medical Info
Suviray® 70 mg/mL (Erenumab) is a targeted prescription medication classified as a monoclonal antibody and a calcitonin gene-related peptide (CGRP) receptor antagonist. It is indicated for the preventive treatment of chronic and episodic migraines in adult patients. By blocking CGRP receptors—a key neurological pathway responsible for transmitting pain signals and dilating cranial blood vessels—this advanced biologic therapy effectively reduces the monthly frequency and severity of debilitating migraine attack.
Storage & Safety
Precautions & Warnings
Reconstitute only with the prescribed quantity of clean drinking water. Shake well before each use. Complete the full course as prescribed. Discard any unused suspension after 7 days of reconstitution.
Storage
Store in a cool, dry place below 25°C. Protect from light and moisture. Refrigeration after reconstitution is preferred.
Status
Keep all medicines out of reach of children.
